导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.08% | 956/1050 |
| 近一周 | -1.40% | 542/1104 |
| 近一月 | -10.73% | 1073/1103 |
| 近一季 | -22.95% | 1020/1092 |
| 近半年 | -25.36% | 1038/1070 |
| 近一年 | -9.80% | 742/1018 |
| 近两年 | 32.36% | 663/926 |
| 近三年 | 3.16% | 648/834 |
| 成立以来 | 263.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.06% 85/1070 |
0.12% 698/1101 |
- - |
- - |
| 2025 | 37.26% 363/1065 |
-0.89% 852/1014 |
-4.03% 933/1038 |
47.39% 104/1050 |
-2.09% 561/1065 |
| 2024 | -4.11% 676/1011 |
-3.34% 497/960 |
-10.16% 870/983 |
15.53% 201/991 |
-4.43% 629/1011 |
| 2023 | -13.77% 469/952 |
3.37% 416/880 |
-4.45% 491/895 |
-8.32% 520/915 |
-4.77% 477/952 |
| 2022 | -26.72% 546/867 |
-14.88% 255/773 |
15.30% 115/806 |
-18.62% 727/845 |
-8.25% 743/867 |
| 2021 | 43.73% 27/740 |
-10.32% 499/580 |
39.32% 13/659 |
12.64% 41/704 |
2.13% 349/740 |
| 2020 | 120.65% 11/554 |
-14.61% 408/419 |
37.95% 40/466 |
14.48% 153/517 |
63.62% 1/554 |
| 2019 | 50.49% 144/410 |
28.62% 448/1146 |
-8.50% 933/1228 |
-0.21% 337/390 |
28.14% 1/410 |
| 2018 | -25.25% 150/349 |
- - |
-7.32% 290/990 |
-13.77% 925/1000 |
-4.46% 50/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 华夏能源革新股票A VS. 东吴新产业精选股票A(580008) |